Skip to main content

Table 3 Learning needs of hospitals on AMS

From: Assessing the impact of the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) on hospital antimicrobial stewardship programmes: results of a worldwide survey

  n (%)
High-income countries (n = 76) Low- and middle-income countries (n = 156) Total (n = 232) P-value (α = 0.0036)
Optimising therapeutic antimicrobial use 43 (56.6) 105 (67.3) 148 (63.8) 0.147
Optimising surgical prophylaxis 38 (50.0) 91 (58.3) 129 (55.6) 0.290
Translating PPS results into AMS interventions 38 (50.0) 71 (45.5) 109 (47.0) 0.615
Communicating with prescribers 35 (46.1) 61 (39.1) 96 (41.4) 0.386
Managing difficult-to-treat MDRO infections* 25 (32.9) 71 (45.5) 96 (41.4) 0.091
Identifying the low-hanging fruit for AMS in the hospital 38 (50.0) 56 (35.9) 94 (40.5) 0.056
Translating PPS results into IPC** interventions 17 (22.4) 61 (39.1) 78 (33.6) 0.017
Formulating/revising guidelines 21 (27.6) 54 (34.6) 75 (32.3) 0.359
Performing audit and feedback 17 (22.4) 54 (34.6) 71 (30.6) 0.081
Understanding antimicrobial susceptibility data 15 (19.7) 55 (35.3) 70 (30.2) 0.024
How to create an active stewardship committee/team 9 (11.8) 41 (26.3) 50 (21.6) 0.019
How to communicate with patients on antimicrobial use 13 (17.1) 28 (18.0) 41 (17.7) 1.000
Other learning needs 1 (1.3) 2 (1.3) 3 (1.3) 1.000
None 2 (2.6) 0 (0.0) 2 (0.9) 0.106
  1. *MDRO: multi-drug resistant organisms; **IPC: infection prevention and control †Statistical significance evaluated using the Pearson’s chi-squared test or Fisher’s exact test. Significance level (α) has been corrected for multiple testing